Evoke Pharma (EVOK) Profit After Tax (2020 - 2025)
Historic Profit After Tax for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to -$1.2 million.
- Evoke Pharma's Profit After Tax rose 1190.06% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year increase of 1497.85%. This contributed to the annual value of -$5.4 million for FY2024, which is 3131.43% up from last year.
- Latest data reveals that Evoke Pharma reported Profit After Tax of -$1.2 million as of Q3 2025, which was up 1190.06% from -$1.6 million recorded in Q2 2025.
- In the past 5 years, Evoke Pharma's Profit After Tax ranged from a high of -$1.2 million in Q3 2025 and a low of -$2.6 million during Q1 2021
- In the last 5 years, Evoke Pharma's Profit After Tax had a median value of -$1.8 million in 2022 and averaged -$1.8 million.
- In the last 5 years, Evoke Pharma's Profit After Tax skyrocketed by 6712.34% in 2021 and then tumbled by 2397.05% in 2025.
- Over the past 5 years, Evoke Pharma's Profit After Tax (Quarter) stood at -$1.7 million in 2021, then fell by 7.82% to -$1.8 million in 2022, then dropped by 10.21% to -$2.0 million in 2023, then skyrocketed by 39.98% to -$1.2 million in 2024, then increased by 3.06% to -$1.2 million in 2025.
- Its Profit After Tax was -$1.2 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$1.3 million in Q1 2025.